Lawmakers seek marketing info

Share this article:
The House Committee on Oversight and Government Reform has asked five drug and medical device companies for documents on their marketing practices. The requests are part of the subcommittee’s heightened oversight of marketing in the drug and device industry.

Letters were sent to Eli Lilly, AstraZeneca, Boston Scientific, Cordis and Cephalon.

The letters ask for information on clinical trials, compensation to experts, explanations for why some unpublished studies were not published, any marketing department support for studies, information given to company and consultant sales personnel, and other items.

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...